
BlueRock Therapeutics launches with $225mm Series A round from Bayer, Versant
Executive Summary
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com